Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Rang în acțiuni #1986
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preț acțiune
$177.09
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$10.45B
Schimbare (1 zi)
1.76%
Schimbare (1 an)
131.10%
Țară
US
Tranzacționează Glaukos Corporation (GKOS)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Glaukos Corporation (GKOS)
Cel mai mare preț de închidere: $166.80 pe 2026-10-01

Cel mai mic preț de închidere: $29.05 pe 2015-06-01
Istoric al prețului acțiunii pentru Glaukos Corporation din 2015 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE